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Abstract
Background: In order to elucidate tumoral progression and drug resistance, cultured cell lines
are valuable tools applied on tumor related assays provided they are well established and
characterized. Our laboratory settled the NG97 cell line derived from a human astrocytoma grade
III, which started to develop and express important phenotypical characteristics of an astrocytoma
grade IV after injection in the flank of nude mice. Astrocytomas are extremely aggressive
malignancies of the Central Nervous System (CNS) and account for 46% of all primary malignant
brain tumors. Progression to worse prognosis occurs in 85% of the cases possibly due to changes
in cell tumor microenvironment and through biological pathways that are still unclear.
Methods:  This work focused on characterizing the NG97 cell line specifically after being
recovered from the xenotransplant, who maintained their undifferentiated characteristics along the
following 60th passages in vitro. These cells were subcultivated to evaluate the possible contribution
of these undifferentiated characteristics to the malignant progression phenotype. These
characteristics were the expression of molecules involved in the processes of migration,
dedifferentiation and chromosomal instability.
Results: Results showed that NG97(ht) had an decrease in doubling time through sub cultivation,
which was characterized by a converse modulation between the expression of glial fibrillary acidic
protein (GFAP) and vimentin. In addition, β1 integrins were present in intermediate levels while α5
integrins had a high expression profile as well as fibronectin and laminin.
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Cytogenetic analysis of NG97(ht) revealed several chromosomal abnormalities, 89% of the cells
showed to be hyperdiploid and the modal number was assigned to be 63. Several acrocentric
chromosomes were visualized and at least 30 figures were attributed to be murine. These findings
suggest a possible fusion between the original NG97 cells with stromal murine cells in the
xenotransplant.
Conclusion: In this study the NG97(ht) cells were characterized to embryonic recovery patterns
of intermediate filaments, adhesion molecules expression, chromosomal imbalances and murine
chromosomes. In the latter case, these presumably chromosomes were originated as fusions
between murine stroma cells and NG97 cell lineage in the xenotransplant. Our results emphasize
important queries about astrocytomas tumor progression.
Background
Astrocytomas are highly aggressive tumors that account
for around 46% of all the primary malignancies of the
Central Nervous System (CNS), demonstrate poor prog-
nosis and statistics show a 5-year survival ranging from
22% for astrocytomas-grade III to only 2% for astrocyto-
mas-grade IV after diagnosis [1]. The treatment is surgical
excision followed by adjuvant chemotherapy [2] and radi-
otherapy; however, many patients exhibit recurrences due
to intrinsic drug resistance within 2 years following the
removal of the tumoral mass, leading to death [3].
A better understanding of tumor dynamics and progres-
sion pathways will improve both diagnosis and therapeu-
tics. For this regard, many laboratories have established
cell lines from tumors [4-7]. In the same way, the NG97
glioma cell line was recently established in our laboratory
after the removal of a tumor mass from a patient who had
been diagnosed with an astrocytoma grade III [8]. The
subcutaneous inoculation of NG97 cells in the flank of
athymic mice (nu/nu) resulted in the development of
solid tumor masses, demonstrating its tumorigenicity [8].
When the tumor mass was excised and examined, a spon-
taneous tumor progression was confirmed by the presence
of prominent vascularity, presence of pseudopalisading
cells and increase of GFAP which were compatible with a
grade IV astrocytoma or glioblastoma multiforme [9].
Cells from the tumor mass were then processed and culti-
vated in vitro as an adherent monolayer and had the same
morphological characteristics of the original culture,
before the xenotransplant [8].
Many authors report the tumor progression phenotype as
a result of expression of dedifferentiated characteristics of
the cells. During the embryonic development of the CNS,
astrocytes hypothetically are originated from progenitors
that solely express vimentin as a cytoskeleton filament
[10,11]. These cells have a migratory pattern and before
they migrate to the glia radial, they express vimentin and
GFAP during cell maturation period [12]. By the end of
this process, mature cells express mainly GFAP [13] as a
cytoskeleton protein. In the adult brain, most of glial cells
express GFAP and this expression can be modified in the
course of many diseases such as Alzheimer's when they
become positive or even negative as in astrocytomas [14].
For these tumors, a GFAP and vimentin proteomics mod-
ulatory pattern was described in patients who progressed
from grade III to IV [15,16].
The migration pattern presented by glioma cells can be
associated to the progenitor and embryonic CNS cell
migration [17]. The transformed cells that reach a malig-
nant progression, acquire the ability to migrate through
tissues in the tumor microenvironment, consequently
resulting in tumor mass growth. This infiltration ability is
driven by a set of molecules called integrins and their
receptors in the extracellular matrix [18]. In gliomas, the
most representatives of this group are a quite a few forms
of α and β1 integrins, laminin and fibronectin. [19-21].
Considering the tumor progression, since 70's decade,
there is a consensus about the genetic instability resulting
in clones that would become more aggressive after succes-
sive mitotic divisions [22]. About five decades earlier,
Boveri (1929) [23] observed that sea urchin eggs experi-
mentally fertilized with two (rather than one) sets of sper-
matozoa underwent abnormal mitosis and proposed that
the deregulated growth of cancer cells might also be a
result of chromosomal imbalance. These findings have
led some researchers to postulate that in vivo cell fusion in
cancer [24] would not only be responsible for chromo-
somal abnormalities, but also for the acquisition of the
malignant phenotype and metastasis promotion [25,26].
In this study, we investigated the expression of astrocytic
molecules of embryonic origin, adhesion and deadhesion
molecules and the cytogenetic patterns of the NG97(ht);
and its characterization may clarify the tumor spontane-
ous progression into astrocytoma.
Methods
Cell culture
The NG97(ht) xenotransplanted cultures were derived
from the NG97 cell line. It was firstly described in 2001BMC Cancer 2008, 8:291 http://www.biomedcentral.com/1471-2407/8/291
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[4] and obtained through the excision, cutting and enzy-
matic digestion of the tumor mass of the xenotransplant
and in vitro cultivation of the small pieces, according to
the explant technique. Subcultures were carried out in D-
valine-containing Eagle's minimal Essential Medium
(GIBCO) supplemented with 2 mmol/L L-glutamine, 10
mmol/L HEPES, 100 U/mL penicillin, 100 μg/mL strepto-
mycin, and 10% heat-inactivated fetal calf serum (Nutri-
cell, Campinas-SP-Brazil) and stocked as described before
[4]. After being defrost and adapted to the cultivation for
five passages, cells were cultivated by more than a hun-
dred passages in RPMI-1640, supplemented with 13%
heat-inactivated fetal calf serum (Nutricell, Campinas, SP,
Brazil) and 25 μg/mL streptomycin. Cultures were main-
tained in a humidified atmosphere at 37°C and 5% CO2.
The medium was changed after intervals of 24 h when the
culture almost reached confluence. Sub culturing was per-
formed after treatment with trypsin and versene (Adolfo
Lutz, São Paulo, SP, Brazil). In this moment, the
NG97(ht) cell line was underwent about 120 passages.
Subcultivations growths curves and cells passages doubling 
time
The amount of 1 × 104 cells of NG97 cells was cultivated
in triplicates on 24-well plate for 11 days to determine the
growth curve. After processing the cultures with the rou-
tine TVS solution treatment (tripsin-versene solution),
aliquots of the cell suspension obtained was diluted daily
in 1% trypan blue in RPMI medium and counted in a
Newbauer chamber.
The number of cells duplications in culture was calculated
according to the formula: (1.1) N = N0 × 2n, where "N" is
the final number of cells after 11 days of culture, N0 the
number at the beginning of the exponential growth phase
of culture and "n" the number of duplications in the
amount of cells.
For the determination of the doubling time (T), the fol-
lowing formulas were used: (1.2) g = t - t0, where "t" rep-
resents the final time in hours when "n" was determined
(as described and determined above in (1.1) equation)
and "t0"the initial time when N0 was studied. Each final
cell doubling time was obtained by the mathematical for-
mula: T = g/n [27].
Western blotting reaction
total protein extraction was carried out after cells being
homogenized in 1% Triton X-100, 50 mM PB pH 7.4, 1
mM sodium pirophosphate, 1 mM sodium fluoride, 5
mM EDTA, 1 mM sodium vanadate, 1% protease inhibi-
tor cocktail (P8340 Sigma), 7 M Urea, 2 M Tiourea. Sam-
ple homogenization was carried out at 4°C using a
Politron 20 s generator (Brinkmann) set at maximum
speed for 30 seconds. To remove insoluble materials, cen-
trifugation (12,000 g centrifugation, 4°C for 15 minutes)
was performed. Protein concentration was determined
using the Bradford method [28]. Total protein extracts
from each cell sample were eletrophoretically separated in
SDS-PAGE and electro blotted to a nitrocellulose mem-
brane according to standard procedures [29]. Membranes
were blocked with PBS-tween® containing 5% non-fat dry
milk and than incubated with an anti-GFAP (polyclonal
antibody, rabbit anti-bovine GFAP) (cat. no. Z0334 from
DakoCytomation, California, USA) and anti vimentin
(mouse monoclonal antibody, Vim clone 3B4) (DakoCy-
tomation, California, USA) diluted (1:1,000) in PBS-
tween containing 3% BSA for 12 h at 4°C. Membranes
were washed with PBS-tween® and incubated with HRP
labeled secondary antibody (Zymed, 1:10,000). Reactive
bands were detected with the SuperSignal West Pico
chemiluminescent kit (Pierce).
Immunocytochemistry
NG97(ht) cells from the 19th to 83rd passages were grown
on 13 mm sterile rounded cover slips which were rinsed
three times in phosphate saline buffer (PBS), pH 7,4 at RT,
and treated with 3% H2O2  in methanol to suppress
endogenous peroxidase activity. After being washed in
PBS, slides were treated with 1% normal mouse serum at
RT for 1 hour. The slides were washed again in PBS, and
then incubated overnight at 4°C with the following anti-
bodies for GFAP (anti-rabbit polyclonal anti-GFAP, cat.
no. Z0334 from DakoCytomation, California, USA) and
anti-vimentin (mouse monoclonal antibody, clone V9,
DakoCytomation, California, USA). All incubations were
carried out in a darkened, humidified chamber at RT. After
being washed in PBS, the slides were incubated with
labeled polymer horseradish peroxidase anti-mouse/anti-
rabbit (EnVysion plus® System, DakoCytomation; Carpin-
teria, CA, USA) for 1 hour at RT. Peroxidase enzyme activ-
ity was visualized by DAB solution (DAKO liquid DAB
substrate-chromogen solution). To stop the reaction dis-
tilled water was applied. The slides were then weakly
counter-stained with Harris' Haematoxylin, dehydrated in
an ethanol series and mounted in Permount® medium.
The images were captured with a Nikon microscope con-
nected to an image acquiring system (Leyca® system). Pos-
itive cells were counted using specific software (Pro-plus
4.3 software®). For each batch positive and negative con-
trols were used.
Flow Cytometry
Cells from the 22nd, 54th and 92nd passages were harvested
from culture flasks, washed and re-suspended in cold PBS
supplemented with 0.5% BSA. Then, cells were incubated
for 30 minutes at RT in the dark with monoclonal mouse
antibodies such as: anti-β1-PECy5, anti-α4-PE, anti-α5-
PE, anti-α6-PE and isotypes controls such as mouse IgG-
PECy5 and IgG-PE (BD biosciences®-Pharmingen, Moun-BMC Cancer 2008, 8:291 http://www.biomedcentral.com/1471-2407/8/291
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tain View, CA, USA). The expression of these surface mol-
ecules were analyzed by flow cytometry (FACSCalibur®,
BD Biosciences, Mountain View, CA, USA) and quantified
by WinMdi®  shareware software. The cloned human
thymic epithelial cell line described by Fernandez and co-
workers [30] was included as a positive control for the
flow cytometry reaction.
Immunofluorescence
the slides containing NG97(ht) were rinsed in PBS and
incubated for 1 h at 37°C with mouse anti-human
fibronectin and anti-human laminin antibodies (BD Bio-
sciences, Mountain View, CA, USA). For detection, slides
were incubated for 2 hours at RT with FITC-conjugated
rabbit anti-mouse serum (Santa Cruz Biotechnology Inc.,
California, CA, and USA). Slides were mounted using the
ProLong Antifade Kit (Molecular Probes, Eugene, OR,
USA) according to the manufacturer's instructions, and
immunoreactions were viewed using an Olympus fluores-
cent microscopic coupled to a Kodak camera. Negative
controls in which normal mouse immunoglobulin was
substituted by the primary antibody were included as well
as positive controls with the cloned human thymic epithe-
lial cell line described elsewhere [30].
Cytogenetics
The analysis of the 20th passage was obtained after routine
cell culture for karyotype. Briefly metaphase spreads were
obtained after 6-hour incubation with 100 μl of Karyo-
max 10 μg/ml (GIBCO). GTG and C-banding were
assessed through standard banding protocols. Image anal-
ysis and acquisition were performed in a Zeiss Axioplan
microscope 2 ® equipped with the BandView software
(Applied Spectral Imaging). The results of the several anal-
yses were compaired at the same passage or, when it is
impossible, in a representing of a near passage for analy-
sis.
Statistical analysis
A linear regression was calculated to verify a relation
between the duplication time and the progression of cell
passages in culture, with the software SYSTAT 10, 2 for
Windows (SYSTAT Software Incorporation, 2002). For the
validation of the described model, the analysis of residues
was also assessed.
Results
Cell Growth Kinetics
The NG97(ht) cell growth was observed in the 19th, 24th,
32nd, 43rd, 59th, 65th and 73rd cell passages. This study of
several passages in culture improves the knowledge about
the maintenance or lack of all features observed in these
cells from in vivo tumoral mass to cells in long-term sub-
cultivation in vitro.
All curves revealed a typical pattern of cell kinetics and
growth including four distinct phases: an initial phase
which is represented by slight cells divisions (i), followed
by an exponential growth (ii) and a stationary phase (iii).
An end phase represented by a growth decline as well as
cell death (iv) is shown in figure 1. The doubling time was
calculated for each cell passage (Table 1) assayed and the
statistical analysis showed a negative linear correlation
between the NG97(ht) doubling time through the subcul-
tivation passages, which demonstrates a significant dou-
bling time decrease (fig. 2A). This linear model regression
was validated by residual analysis (R2 = 715,415; F1,25 =
30,597 e P << 0,001) as represented in fig. 2B.
GFAP and vimentin patterns
In order to assess the ontogenic protein patterns and their
stability through cell subcultivation: early (until 50th),
middle (from 51st to 79th) and later (after 80th) NG97(ht)
cell passages were analyzed.
Western Blot (WB) reactions showed that cells expressed
basal amounts of GFAP (fig. 3A) and Vimentin (fig. 3B)
cytoskeleton proteins in the cytoplasm fraction contain-
ing 5 μg and 30 μg amounts of proteins, respectively. In
particular, another molecular weight (approximately 41,8
kDa) for vimentin was also registered from protein degra-
dation during 33rd cell passage protein extraction by soni-
cation.
This observed GFAP detection did not represent the func-
tional molecular polymerized expression. These GFAP
and vimentin cytoskeletons conformational arrange-
ments were demonstrated by immunocytochemistry and
suggested a modulation pattern through cell subcultiva-
tion. An intense cytoplasmatic staining for GFAP was
observed in 100% of cells in the 19th cell passage (fig. 4A).
The same pattern was present in approximately 85% of
the NG97(ht) cells in the 30th (fig. 4B) and, finally, totally
absent in 51st (fig. 4C) and 80th (fig. 4D) cell passages.
Nevertheless, it was shown an absence of staining for cyto-
Table 1: Increase of cell proliferation by doubling culture time 
decreased calculated to NG97(ht) trough cell subcultivation
Cell passages Doubling time (hours)
19 30
24 32
32 36
37 29
43 23
51 23
59 17
65 21
73 19
* Approximated values.BMC Cancer 2008, 8:291 http://www.biomedcentral.com/1471-2407/8/291
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Representative cell growth graphics of different NG97(ht) cells passage through subcultivation: 19th (A), 24th (B), 32nd (C), 37th  (D), 43rd (E), 51st (F), 59th (G), 65th (H) e 73 rd (I) Figure 1
Representative cell growth graphics of different NG97(ht) cells passage through subcultivation: 19th (A), 24th 
(B), 32nd (C), 37th (D), 43rd (E), 51st (F), 59th (G), 65th (H) e 73 rd (I).BMC Cancer 2008, 8:291 http://www.biomedcentral.com/1471-2407/8/291
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plasmatic vimentin in the 21st cell passage (fig. 4E), fol-
lowed by weakly stained areas in the 40th NG97(ht) cell
passage (fig. 4F). Approximately 54% of NG97(ht) cells in
the 59th passage (fig. 4G) and, finally, a markedly positive
staining in the 83rd cell passage (fig. 4H).
Expression of integrins and their receptors
Flow cytometry was applied on passages 22nd, 54th and
92nd for the assay of β1, α4, α5 and α6 subunits (Table 2).
The table 2 shows a low average expression of the β1 chain
(52,72%) through cell subcultivation, when compared to
the α5 subunit that presented an average of 98,32% of
positive cells through sulbcultivation. The α4 and α6
integrins were not detected. The positive control, a cloned
human thymic epithelial cell line established by Fernan-
dez and co-workers [30], showed a 95–99% range of
expression through flow cytometry for β1, α4, α5 and α6
subunits (not shown).
Fibronectin and laminin staining was performed on fixed
cells, which may illustrate the intracellular and extracellu-
lar presence of proteins on living cells. A punctate
fibronectin and laminin immunoreactivity mainly located
in the perinuclear area was observed (fig. 5A and 5B),
whereas a fibronectin labelled network and immunoreac-
tive intercellular fibrils were clearly detected in NG97(ht)
cells (fig. 5A). In some cells with a known migratory pat-
tern, it was evidenced the accumulation of fibronectin in
the lamelipodia cytoplasm extensions. The same pattern
was observed for laminin and seems to be more intense in
polinucleated cells (fig. 5B). The positive control, the
cloned human thymic epithelial cell line [30], presented
both intracellular and extracellular fibronectin and lam-
inin expressions (not shown).
Structural and Numerical Chromosomal Abnormalities
GTG-band staining applied to the 20th passage of the
NG97(ht) cells revealed remarkably fused, translocated
segments and acentric fragments (fig. 6A), while several
regions of heterochromatin, dicentrics and acrocentric
chromosomes were visualized by C-banding (fig. 6B).
The analysis of 100 metaphases showed more than 50
numerical and structural abnormalities, with a modal
number of 63 chromosomes. In addition, 89% of met-
aphases exhibit a range of 20 to 49 acrocentric chromo-
somes showing a strong correlation with murine banding
pattern (fig. 7). The most frequent numerical abnormali-
ties were the monosomies (2, 5, 11, 16, 17 and X), triso-
mies (1,10,14,15,16 and 19), the tetrasomies (4 and 6), as
well as structural alterations like isochromosome forma-
tions (murine chr 4 and chr 14), disbalanced fusion
(murine: ?→ chr 1) and pericentric inversion (chr 15).
Statistical analysis to validate the significance of the NG97(ht) doubling time decrease Figure 2
Statistical analysis to validate the significance of the NG97(ht) doubling time decrease. The simple linear regres-
sion was used and show the correlation between cell doubling time (plotted in "Y" axis) and the cell passages at subculture, 
which was represented by ordinal values (plotted in "X" axis). The equation that describes the linear regression mathematical 
model was y = 35.379-1.994x (A). (B) This graphic represents the residual analysis to validate the mathematic model (R2 = 
715,415; F1,25 = 30,597 and P << 0,001).BMC Cancer 2008, 8:291 http://www.biomedcentral.com/1471-2407/8/291
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Discussion
Several studies have associated astrocytomas malignant
progression with amplification, over expression or muta-
tion of specific gene sequences [31]. Considering that
morphological alterations of the neoplastic tissue are
directly linked to these genetic changes, researches have
tried to establish which chromosome alterations are
directly linked to astrocytomas progression [32,33]. The
absence of this correlation is partially due to the fact that
astrocytomas present an intrinsic chromosomal instabil-
ity pattern even in different intra-tumoral regions, disa-
bling this direct correlation.
In vivo xenograph tumor models developed by subcutane-
ous implantation of glioma cell lines in mice are exten-
sively used [6,7] to test therapeutical approaches that
target angiogenesis, local invasion and secretion of
immune suppressive molecules. These models have the
advantages that they are highly tumorigenic, show repro-
ducible growth rates and because their superficial location
allows an easily access to tumoral masses. Besides,
tumoral mass volume in these dorsal models would
mimic the original astrocytoma volume [34] and repro-
duce the hypothetical "vicious cycle of thrombosis, necro-
sis, hypoxia, enhanced tumor and metabolic demand" to
the development of GBM [35]. Moreover, stable cell cul-
tures derived from these tumors are important tools to
therapeutical and biological analysis. However, for immu-
notherapeutical approaches, the flank microenvironment
cells in culture represents a limitation to these models
once the inflammatory cytokines and infiltrating cells
profile have must be considered for data analysis [36].
The modulatory pattern of intermediate filaments GFAP 
and vimentin microarchitectural arrangement in NG97(ht) 
cells
The astrocytes embryogenic origins can be evaluated by
the expression of GFAP, in particular after migration of
the progenitor to the radial glia during the CNS develop-
ment; which is dependent of chemical mediators present
in the brain microenvironment [37]. This migratory phase
is accompanied by an early vimentin expression, an indic-
ative of the neuroectodermical glial precursor origin.
Vimentin establishes a link with microtubules or cytoskel-
eton filaments to form a dynamic polymerization and
depolymerization balance that allows cellular motility
[38]. Besides, some glial precursors have a transitory
phase named astrocytes type I, where vimentin and GFAP
are expressed, which in adulthood originates oligo-
ndendrocytes [37]. Thus, the modulatory GFAP and
vimentin expression pattern presented by the NG97(ht)
cells showed that through cell subcultivation, the reduced
immunocytochemistry detection of GFAP is associated to
an increased detection of vimentin which may account for
the recovery of embryonic characteristics. This feature is
observed in other glioma cells [39] and patients diag-
nosed with astrocytoma grade III and IV [15,16]. Together
with GFAP immunodetection decrease and vimentin
enhance patterns; there is an increase on cell mitosis con-
comitant to a decline in cell doubling time. This may be
associated with loss of GFAP expression in vivo, frequently
found in high grade astrocytomas, although this event
does not constitute a mandatory step in tumor develop-
ment and it only represents the cell evolution towards an
undifferentiated state. In this sense, some kinases related
to cell cycle regulation, like kinases C and cdc2, also may
participate of phosphorylation and depolymerization
processes of cytoskeleton intermediary filaments at the
Western Blot of NG97(ht) from different cell passages sub- cultivation to (A) GFAP and (B) vimentin, which contained  approximately 5 μg and 30 μg of protein cytoplasm fraction,  respectively Figure 3
Western Blot of NG97(ht) from different cell pas-
sages subcultivation to (A) GFAP and (B) vimentin, 
which contained approximately 5 μg and 30 μg of 
protein cytoplasm fraction, respectively. Lines 1, 2 and 
3 show 23rd, 33rd e 95th cell passages, respectively. (A) Note 
the GFAP basal linear conformational protein expression 
banded at approximated 50 kDa molecular weight in all pas-
sages. (B) Note the vimentin linear conformational basal 
expression banded at approximated 50 kDa molecular 
weight at earlier and later passages, though a 41,8 kDa 
molecular weight banded the 33rd cell passage resulted from 
a partial vimentin degradation by the protein sonication 
extraction procedure.(Positive and negative controls were 
assayed but were omitted here).BMC Cancer 2008, 8:291 http://www.biomedcentral.com/1471-2407/8/291
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GFAP and vimentin immunocytochemistry through cell subcultivation Figure 4
GFAP and vimentin immunocytochemistry through cell subcultivation. Notice the negative modulatory expression 
pattern to GFAP (A – D) concomitant to the positive modulatory pattern to vimentin (E-H) in NG97(ht). The GFAP appears 
intensely marked in 100% of the 19th cell passage cytoplasm (A), being presented in approximately 85% of the 30th (B) and, 
finally, totally absent in 51st (C) and 80th (D) cell passages. Nonetheless, the vimentin were absent at 21st (E) cell passage, pre-
sented in weakly areas in the 40th (F) and in 54% of the 59th (G) cell passage and, finally, markedly positive at 83rd (H) cell pas-
sage (Original magnification: A – C and E – G = 200× and D and H = 1000×) (Positive and negative controls were assayed but were not 
displayed here).BMC Cancer 2008, 8:291 http://www.biomedcentral.com/1471-2407/8/291
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beginning of cell division. So, the absence of the main
component of astrocytes cytoskeleton, GFAP, would
increase enzyme accessibility to substrats, resulting in pro-
gressive cell cycle acceleration [40]. It is also important to
note that the increase of positive vimentin cells cannot be
attributed to the possible NG97 cell fusion with the
murine stroma in the xenotransplant, because the mono-
clonal antibodies anti-vimentin clone V9 used in the
immunocytochemistry recognizes specifically the human
vimentin [41]. However, the monoclonal antibodies anti-
vimentin 3B4 clone used in Western Blot reaction recog-
nizes both human and murine proteins. Thus, Ciesielski-
Treska and colleagues documented before the ~41,8 kDa
vimentin sub band as an artifact resulted from protein
extraction [42].
High migratory and malignant potential driven by the 
NG97(ht) expression of α5β1, fibronectin and laminin
The increased aggressiveness of astrocytomas is accompa-
nied by the acquisition of cellular migratory potential
[18], from the modulation of integrins and their receptors
expression with an increase of lamellipodia cytoplasm
extensions and diminution of focal adhesion to the extra-
cellular matrix [43].
Integrins are composed of two non covalently associated
subunits (α and β) that form a binding pocket for specific
sequences or domains in extracellular matrix (ECM) mol-
ecules; the most well known is the tripeptide RGD
(argenin-glycin-aspartic acid) domain found in fibronec-
tin and laminin ECM molecules. In gliomas, the α4, α5
and α6 molecules combined with β1 subunit in cellular
membrane form the integrin adhesion molecules that can
also play a role in intracellular cell signaling that leads, at
last, to promote an increase in proliferation rates [44].
This integrin molecule heterodimerization and clustering
can be modulated by RGD polypeptides concentration
[44]. The absence of α4β1 expression observed in
NG97(ht) was also documented previously in gliomas
cell lines [44]. Besides, some studies only demonstrated
the expression of α5β1, α6β1 and their ligands both in
vivo  and  in vitro. The fibronectin ligand for the α5β1
integrin was described by some authors to be increased or
decreased in gliomas influencing its invasive patterns. A
high-level expression of α5 monomeric integrin concom-
itant to the β1 intermediate expression was observed, sug-
gesting an unfunctional α5β1 integrin expression. Indeed,
some authors describe this fact as a result of differential
interaction of integrin molecules in different tumoral
mass regions. Specifically in the tumor core, α5β1 is func-
tionally expressed to modulate cell divisions, while α5β1
interaction with fibronectin in the ECM induces cell
Table 2: Absence of α4 and α6 integrin subunits.
NG97(ht)
Markers early middle Later average SD
β1 (CD29) 49,0 58,47 50,70 52,72 5,04
α4 (CD49d) 0,0 0,0 0,0 0,0 0,0
α5 (CD49e) 98,03 98,72 98,21 98,32 0,35
α6 (CD49f) 0,0 0,0 0,0 0,0 0,0
Intermediate β1 and high α5 integrin expression levels in: earlier 
(22nd), middle (54th) and later (92nd) NG97(ht) cell passages by flow 
cytometry. The results showed the percentage of positive cells, the 
average of positivity for each marker and the standard deviation (SD).
*Representative values of 104 cells NG97(ht) analyzed. (Positive 
controls with the cloned human thymic epithelial cell line was assayed 
but was not displayed here).
Immunofluorescence in the NG97(ht) 20th cell passage for  (A) fibronectin and (B) laminin expression which were repre- sented by a diffusely cytoplasmatic pattern, hot spot areas (#)  and some fibrils (*) deposition in the ECM and increase of  polymerization in the lamelipodia cytoplasmatic extensions  (arrow) (original magnification: 400×) Figure 5
Immunofluorescence in the NG97(ht) 20th cell pas-
sage for (A) fibronectin and (B) laminin expression 
which were represented by a diffusely cytoplasmatic 
pattern, hot spot areas (#) and some fibrils (*) depo-
sition in the ECM and increase of polymerization in 
the lamelipodia cytoplasmatic extensions (arrow) 
(original magnification: 400×).(Positive controls with cells of 
cloned human thymic epithelial lineage were assayed; however the 
data are not displayed here).BMC Cancer 2008, 8:291 http://www.biomedcentral.com/1471-2407/8/291
Page 10 of 13
(page number not for citation purposes)
Digitalizated images from NG97(ht) cells spread metaphases Figure 6
Digitalizated images from NG97(ht) cells spread metaphases. (A) G-banded chromosomes with 400 bp resolu-
tion showing a large amount of chromosomal imbalances represented by figures of bridge (black arrow) and 
fusioned chromosomes (white arrows). (B) These breakages formed acrocentric (*) and acentric (Φ) chromosomes 
which are evidenced by C-band technique. Notice the dicentrics (arrow head) chromosomes and heterochromatin regions.BMC Cancer 2008, 8:291 http://www.biomedcentral.com/1471-2407/8/291
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migration [45]. It is hypothesized that the reduced β1
integrin and the high expression of α5 would correspond
to an increased expression of the Mgat5 enzyme during
malignant transformation resulting in an increase of β1,6
glycosides ramifications at the β1 subunit. This process
could reduce integrin dimerization and clusterization of
β1 and α5 [46], once the fibronectin is synthesized and
released to the extracellular compartment of the
NG97(ht) cells, this would be a high stimuli to α5β1
expression. In the NG97(ht) cells, no expression of α6β1
integrin was observed, although its laminin ligand was
present in the cytoplasm. It is reasonable to ponder that
the α6β1 expression absence is a result of a lack of stimuli
from the microenvironment once laminins were detected
in the NG97(ht) mainly in the cytoplasm. Further experi-
ments aiming to assess the integrins functionalities in the
cells NG97(ht) will be developed in our laboratory to elu-
cidate these questions.
The chromosomal abnormalities as a possible explanation 
for the spontaneous tumoral progression
Also associated to malignant transformation, chromo-
somal alterations in glioma lineages are poorly described
in the literature, while many cytogenetical evaluations in
patients were reported. Nevertheless, aneuploidy, hyper-
ploidy or numerical abnormalities documentations pre-
sented similarities between literature data in gliomas,
pointing to a correlation with the tumoral phenotype
[47]. Accordingly to some authors, the aneuploid pheno-
type would not be the cause, but the consequence of
cumulative alterations provided by the tumoral microen-
vironment [22,26]. The chromosomal instability caused
Mouse representative diagram and the corresponding NG97(ht) murine kayotype Figure 7
Mouse representative diagram and the corresponding NG97(ht) murine kayotype. Note the murine acrocentric 
chromosomes associated with the cell line composed of isochromosomes (i), fusion (fusion), absences (3 and 13), monosso-
mies (2,5,11,16 and X), trisomies (1,10,14,15,16 and 19), tetrasomies (4 and 6) and chromosomes with pericentric inversion 
(inv).BMC Cancer 2008, 8:291 http://www.biomedcentral.com/1471-2407/8/291
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by cytogenetical heterogeneity is responsible for the
malignant progression but is still to be fully elucidated
[47]. Jacobsen and colleagues [25] demonstrated that
mice inoculated with human-derived breast cancer cell
lines (BC6) presented cell fusion with murine stroma
(BJ3Z), leading to an increased aggressiveness. Pawlek
[24], in his review on melanomas, showed solid evidences
that stroma immune system cells from tumoral host
fusioned with tumoral cells, not only causing aneuploidy
but contributing for other mechanisms related to the
malignant phenotype including aberrant glycosylation
and metastasis. The NG97(ht) karyotyping and immu-
nophenotyping are in agreement with the cell fusion phe-
nomena, once murine chromosomes were observed in the
NG97(ht) cells as well CD86 and CD44 murine proteins
detected by flow cytometry (data not shown). Also, a pos-
sible increase of aggressiveness, given by the reduction of
the doubling time from 72 h at NG97 cell establishment
[8] to currently 25 h was noticed to occur within the
NG97(ht) cells. Nevertheless, the evaluation of these
murine chromosomes translocated fragments with
human chromosomes or vice and versa by concomitant
human/murine Spectral Karyotyping, as well as the possi-
ble chimerisms, must be an objective of future studies. In
addition, the evaluation of human cryptic chromosomes
analysis by Fluorescent Hybridization could be an impor-
tant target for further researches.
Conclusion
The NG97(ht) cells possesses embryonic recovery patterns
of intermediate filaments and adhesion molecules expres-
sion that corroborate the astrocytoma grade IV diagnosis
after NG97 inoculation in nude mice. Furthermore, the
chromosomal imbalances and a tumoral cell fusion with
the murine stroma cells in the xenotransplant give clues to
the spontaneous in vitro cell progression to the most
aggressive astrocytoma phenotype. However, further stud-
ies are necessary to address unanswered questions regard-
ing the in vitro tumoral progression of the NG97(ht) cells,
aiming to translate these events to the clinical practice and
management of astrocytoma tumors.
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